Cite
HARVARD Citation
Shao, Z. et al. (2021). Pertuzumab and trastuzumab as adjuvant treatment for HER2-positive early breast cancer: outcomes in Chinese patients in the APHINITY study. Japanese journal of clinical oncology. pp. 345-353. [Online].